JSPR — Jasper Therapeutics Share News
0.000.00%
Last trade - 00:00Jasper Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Jasper Therapeutics Q2 loss per share beats estimates, raises $132 mln
Jasper Therapeutics, Inc. expected to post a loss of 35 cents a share - Earnings Preview
Jasper Therapeutics rises; co announces all-stock merger with Kira Pharma
NASDAQ RESUMED AT 05:45 PM
NASDAQ TRADE HALT HALT NEWS PENDING AT 05:10 PM
U.S. STOCKS ON THE MOVE-Grail, Kohl, Virgin Galactic
U.S. STOCKS ON THE MOVE-Apple, JetBlue, Cognizant
U.S. STOCKS ON THE MOVE -Revolution Medicines, FedEx, Cummins
Jasper Therapeutics rises as company explores sale, strategic options
Jasper Therapeutics posts Q1 net loss as briquilimab program advances
Brief: Jasper Therapeutics Appoints Jeet Mahal As Chief Executive Officer To Lead Next Phase Of Clinical Growth
NASDAQ RESUMED AT 07:30 AM
Jasper Therapeutics jumps as asthma drug shows early promise
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
Jasper Therapeutics Q3 loss smaller than estimates
U.S. RESEARCH ROUNDUP-Apple, GE Aerospace, Tesla
U.S. STOCKS ON THE MOVE-BILL Holdings, Jackson Financial, Wills Towers Watson
U.S. STOCKS ON THE MOVE-Gold miners, Perpetua Resources, KalVista Pharmaceuticals